2018
DOI: 10.1002/mnfr.201700941
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ‐Induced Diabetic Mice

Abstract: ScopeIn this study, we aim to determine the effects of resveratrol (RSV) on muscle atrophy in streptozocin‐induced diabetic mice and to explore mitochondrial quality control (MQC) as a possible mechanism.Methods and resultsThe experimental mice were fed either a control diet or an identical diet containing 0.04% RSV for 8 weeks. Examinations were subsequently carried out, including the effects of RSV on muscle atrophy and muscle function, as well as on the signaling pathways related to protein degradation and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
56
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(61 citation statements)
references
References 60 publications
5
56
0
Order By: Relevance
“…Many studies have reported that PGC-1α is an important regulator of oxidative capacity in skeletal muscle (Zechner et al 2010;Tadaishi et al 2011;Kang et al 2012). In the present study, the activity of CS, an indicator of oxidative capacity, and expression of COX-4, an enzyme of the mitochondrial respiratory chain, in the skeletal muscle were decreased in rats with STZ-induced hyperglycemia (Figure 2), which is consistent with previous reports (Py et al 2002;Roberts-Wilson et al 2010;Padrão et al 2012;Wang et al 2018). Additionally, the expression level of PGC-1α in the STZ/CO 2 (-) group was significantly decreased compared with that in the CON/CO 2 (-) group (Figure 3).…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Many studies have reported that PGC-1α is an important regulator of oxidative capacity in skeletal muscle (Zechner et al 2010;Tadaishi et al 2011;Kang et al 2012). In the present study, the activity of CS, an indicator of oxidative capacity, and expression of COX-4, an enzyme of the mitochondrial respiratory chain, in the skeletal muscle were decreased in rats with STZ-induced hyperglycemia (Figure 2), which is consistent with previous reports (Py et al 2002;Roberts-Wilson et al 2010;Padrão et al 2012;Wang et al 2018). Additionally, the expression level of PGC-1α in the STZ/CO 2 (-) group was significantly decreased compared with that in the CON/CO 2 (-) group (Figure 3).…”
Section: Discussionsupporting
confidence: 93%
“…It is critically regulated by mitochondrial function represented by adenosine triphosphate synthesis through the tricarboxylic acid cycle. Muscle oxidative capacity depends on mitochondrial enzymatic activity and biogenesis (Short et al 2003;White and Schenk 2012), both of which are decreased by hyperglycemia in diabetes (Patti et al 2003;Boushel et al 2007;Fujimaki and Kuwabara 2017;Wang et al 2018), leading to the decrement of exercise capacity. Therefore, attenuation of hyperglycemia-induced impairment of muscle oxidative capacity is important to maintain exercise capacity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In patients with diabetes, skeletal muscle dysfunction due to mitochondrial deficits may occur, leading to reduced muscle strength. Particularly, mitochondrial homeostasis and mitochondrial quality control are essential for the maintenance of muscle mass since they indirectly control myocyte insulin sensitivity [70].…”
Section: Diabetesmentioning
confidence: 99%
“…Accordingly, resveratrol reduced the expression of two muscle-specific E3 ubiquitin ligases, that is, muscle atrophy F-box (MAFbx)/atrogin-1 and muscle RING-finger protein-1 (MuRF-1), and the expression of LC3-II and cleaved caspase-3. In addition, resveratrol increased the expression of nuclear respiratory factor-(NRF-) 1, cytochrome c oxidase (Cox) IV, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and mitochondrial transcription factor A (mtTFA) and reduced the expression of mitochondrial fission regulatory proteins (e.g., phosphodynamin-related protein 1 (p-DRP1), mitochondrial fission 1 protein (FIS1), and mitochondrial fission factor (MFF)) and mitochondrial fusion regulatory proteins (e.g., p-DRP1 (Ser637), mitofusin-2 (MFN2), and OPA1 mitochondrial dynamin like GTPase (OPA1)) [70].…”
Section: Diabetesmentioning
confidence: 99%